Avisa Diagnostics (FOGCF) Stock Statistics & Valuation Metrics

Avisa Diagnostics has a market cap or net worth of $1.91M. The enterprise value is ―.

Avisa Diagnostics has 43,241,310 shares outstanding. The number of shares has decreased by -2.65% in one year.

Avisa Diagnostics’s return on equity (ROE) is 1.36 and return on invested capital (ROIC) is 241.89%.

The current PE Ratio of Avisa Diagnostics is ―. Avisa Diagnostics’s PEG ratio is ―.

In the last 12 months, Avisa Diagnostics had revenue of 277.83K and earned -715.76K in profits. Earnings per share was -0.14.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Avisa Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―

Avisa Diagnostics upcoming earnings date is ―, ―.

Avisa Diagnostics as a current ratio of 0.23, with Debt / Equity ratio of ―

In the past 12 months, Avisa Diagnostics has paid 0.00 in taxes.

Avisa Diagnostics EV to EBITDA ratio is -5.26, with an EV/FCF ratio of -7.89.

Avisa Diagnostics has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of -324.17%, and net profit margin of -257.63%.

The average price target for Avisa Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―